Clinical Trials for Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Find clinical trials for metastatic castrate resistant prostate cancer (mcrpc). Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

NCT ID: NCT06551324

This clinical trial, called MEVPRO-1, is looking at a new medicine called PF-06821497 (Mevrometostat) to see if it can help men with metastatic castrate-resistant prostate cancer (mCRPC) who have p...

Recruiting

Phase: PHASE3 Type: interventional Locations: Salt Lake City, Utah, United States, Louisville, Kentucky, United States +237 more

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

NCT ID: NCT06943495

The PRODIGY-2 clinical trial is exploring whether a personalized treatment approach using a radiopharmaceutical called 177Lu-PSMA-617 (also known as Pluvicto) is safe and effective for men with met...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Quebec, , Canada

Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial

NCT ID: NCT06720532

The KiRi-Trial is a study designed to understand how a specific treatment for prostate cancer, called 177Lutetium-PSMA Radioligand Therapy, affects kidney function over time. Researchers want to fi...

Recruiting

Type: observational Locations: Munich, , Germany

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions